JAMA Oncology
Brief Report
April 25, 2024
Giacomo Montagna, MD, MPH; Mary M.ÌýMrdutt, MD, MS; Susie X.ÌýSun, MD; Callie Hlavin, MD, MPH; Emilia J.ÌýDiego, MD; Stephanie M.ÌýWong, MD, MPH; Andrea V.ÌýBarrio, MD; Astrid Botty van den Bruele, MD; Neslihan Cabioglu, MD, PhD; Varadan Sevilimedu, MBBS, DrPH; Laura H.ÌýRosenberger, MD, MS; E. Shelley Hwang, MD, MPH; Abigail Ingham, MBchB; Bärbel Papassotiropoulos, MD; Bich Doan Nguyen-Sträuli, MD; Christian Kurzeder, MD; Danilo DÃaz Aybar, MD; Denise Vorburger, MD; Dieter Michael Matlac, MD; Edvin Ostapenko, MD; Fabian Riedel, MD; Florian Fitzal, MD; Francesco Meani, MD; Franziska Fick, MD; Jacqueline Sagasser, MD; Jörg Heil, MD, PhD; Hasan Karanlık, MD; Konstantin J.ÌýDedes, MD; Laszlo Romics, MD, PhD; Maggie Banys-Paluchowski, MD, PhD; Mahmut Muslumanoglu, MD; Maria Del Rosario Cueva Perez, MD; Marcelo Chávez DÃaz, MD; Martin Heidinger, MD; Mathias K.ÌýFehr, MD; Mattea Reinisch, MD; Mustafa Tukenmez, MD; Nadia Maggi, MD; Nicola Rocco, MD, PhD; Nina Ditsch, MD, PhD; Oreste Davide Gentilini, MD; Regis R.ÌýPaulinelli, MD, PhD; Sebastián Solé Zarhi, MD; Sherko Kuemmel, MD, PhD; Simona Bruzas, MD; Simona di Lascio, MD; Tamara K.ÌýParissenti, MD; Tanya L.ÌýHoskin, MS; Uwe Güth, MD; Valentina Ovalle, MD; Christoph Tausch, MD; Henry M.ÌýKuerer, MD, PhD; Abigail S.ÌýCaudle, MD; Jean-Francois Boileau, MD, MSc; Judy C.ÌýBoughey, MD; Thorsten Kühn, MD, PhD; Monica Morrow, MD; Walter P.ÌýWeber, MD
online first
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
JAMA Surgery
Original Investigation
December 13, 2023
Mark E.ÌýSherman, MD; Robert A.ÌýVierkant, MS; Stacey J.ÌýWinham, PhD; Celine M.ÌýVachon, PhD; Jodi M.ÌýCarter, MD, PhD; Laura Pacheco-Spann; Matthew R.ÌýJensen, BS; Bryan M.ÌýMcCauley, BS; Tanya L.ÌýHoskin, MS; Lisa Seymour, BS; Denice Gehling, RN; Jessica Fischer; Karthik Ghosh, MD; Derek C.ÌýRadisky, PhD; Amy C.ÌýDegnim, MD
JAMA Surg. 2023; 159(2):193-201. 10.1001/jamasurg.2023.6382
This cohort study estimates the risk of breast cancer among women diagnosed with histopathologic benign breast disease in the era of percutaneous biopsy vs historical surgical biopsy.
JAMA Surgery
Original Investigation
December 1, 2018
Alison U.ÌýBarron, MD; Tanya L.ÌýHoskin, MS; Courtney N.ÌýDay, BS; E. Shelley Hwang, MD, MPH; Henry M.ÌýKuerer, MD, PhD; Judy C.ÌýBoughey, MD
free access
JAMA Surg. 2018; 153(12):1120-1126. 10.1001/jamasurg.2018.2696
This study of the National Cancer Database evaluated the association of nodal positivity rates with a pathologic complete response to neoadjuvant chemotherapy among patients with cT1/cT2 cN0 triple-negative breast cancer or ERBB2-positive disease.
JAMA Surgery
Paper
July 20, 2009
Sarah Y. Boostrom, MD; Clive S. Grant, MD; Geoffrey B. Thompson, MD; David R. Farley, MD; Melanie L. Richards, MD; Tanya L. Hoskin, MS; Ian D. Hay, MD, PhD
free access
Arch Surg. 2009; 144(7):663-669. 10.1001/archsurg.2009.122
JAMA
Original Contribution
June 22, 2005
Imad M. Tleyjeh, MD; James M. Steckelberg, MD; Hani S. Murad, MD; Nandan S. Anavekar, MD; Hassan M. K. Ghomrawi, MPH; Zaur Mirzoyev, MD; Sherif E. Moustafa, MD, MS; Tanya L. Hoskin, MS; Jayawant N. Mandrekar, PhD; Walter R. Wilson, MD; Larry M. Baddour, MD
free access
JAMA. 2005; 293(24):3022-3028. 10.1001/jama.293.24.3022